as a shareholder of AGL & GNX ... I support this move We need capital to build... and a PPA for offtake - I am sure AGL would do both, but it all comes back to the dollars
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling